文献速递肝病消化道肿瘤与早癌

NAFLD相关肝癌的独特分子特征突显β-catenin/TNFRSF19介导的免疫逃逸

Unique molecular characteristics of NAFLD-associated liver cancer accentuate β-catenin/TNFRSF19-mediated immune evasion.
PubMed 文献 · J Hepatol · 2022-03-26

对100例NAFLD-HCC患者的肿瘤-正常配对样本进行下一代测序,发现CTNNB1突变占33%且与免疫排斥相关,CTNNB1突变上调TNFRSF19进而抑制衰老相关分泌表型样细胞因子(包括IL6和CXCL8),该现象可被Wnt调节剂ICG001逆转。

要点

  • NAFLD-HCC中CTNNB1突变发生率为33%,且与免疫排斥明显相关。
  • CTNNB1突变通过上调TNFRSF19抑制IL6和CXCL8等细胞因子。
  • Wnt调节剂ICG001可逆转CTNNB1突变介导的免疫抑制现象。

核心结论

  • NAFLD和NAFLD-HCC患者肝脏中独特的突变过程提示存在一种「场效应」,涉及CTNNB1功能获得性突变在免疫排斥中的作用。

研究设计与样本

  • 对100例诊断为NAFLD-HCC患者的肿瘤-正常配对样本进行下一代测序。
  • 通过生物信息学分析识别与NAFLD-HCC发病相关的关键基因组、表观基因组和转录组事件。
  • 建立原代患者来源的NAFLD-HCC培养物作为代表性人类模型,用于下游体外研究CTNNB1 S45P驱动突变。
  • 使用同基因免疫活性小鼠模型进一步测试CTNNB1突变和TNFRSF19在重塑肿瘤微环境中的参与。

主要发现

  • NAFLD患者肝脏中发生的突变过程推断通过缺陷DNA修复途径导致肿瘤形成易感性。
  • 密集启动子突变和失调转录因子突显NAFLD-HCC中激活的转录调控,特别是MAZ-MYC活性的富集。
  • NAFLD和乙型肝炎病毒感染所致HCC中常见的体细胞事件强调相似的驱动通路,但发生率变化突显CTNNB1突变在NAFLD-HCC中的主导地位(33%)。
  • 免疫排斥与CTNNB1突变明显相关。
  • 染色质免疫沉淀测序结合转录组和免疫分析揭示独特转录轴:CTNNB1突变导致TNFRSF19上调,后者随后抑制衰老相关分泌表型样细胞因子(包括IL6和CXCL8)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The hepatic manifestation of the metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), can lead to the development of hepatocellular carcinoma (HCC). Despite a strong causative link, NAFLD-HCC is often underrepresented in systematic genome explorations. METHODS: Herein, tumor-normal pairs from 100 patients diagnosed with NAFLD-HCC were subject to next-generation sequencing. Bioinformatic analyses were performed to identify key genomic, epigenomic and transcriptomic events associated with the pathogenesis of NAFLD-HCC. Establishment of primary patient-derived NAFLD-HCC culture was used as a representative human model for downstream in vitro investigations of the underlying CTNNB1 S45P driver mutation. A syngeneic immunocompetent mouse model was used to further test the involvement of CTNNB1mutand TNFRSF19 in reshaping the tumor microenvironment. RESULTS: Mutational processes operative in the livers of patients with NAFLD inferred susceptibility to tumor formation through defective DNA repair pathways. Dense promoter mutations and dysregulated transcription factors accentuated activated transcriptional regulation in NAFLD-HCC, in particular the enrichment of MAZ-MYC activities. Somatic events common in HCCs arising from NAFLD and viral hepatitis B infection underscore similar driver pathways, although an incidence shift highlights CTNNB1mut dominance in NAFLD-HCC (33%). Immune exclusion correlated evidently with CTNNB1mut. Chromatin immunoprecipitation-sequencing integrated with transcriptome and immune profiling revealed a unique transcriptional axis, wherein CTNNB1mut leads to an upregulation of TNFRSF19 which subsequently represses senescence-associated secretory phenotype-like cytokines (including IL6 and CXCL8). This phenomenon could be reverted by the Wnt-modulator ICG001. CONCLUSIONS: The unique mutational processes in the livers of patients with NAFLD and NAFLD-HCC allude to a "field effect" involving a gain-of-function role of CTNNB1 mutations in immune exclusion. LAY SUMMARY: The increasing prevalence of metabolic syndrome in adult populations means that NAFLD is poised to be the major cause of liver cancer in the 21st century. We showed a strong "field effect" in the livers of patients with NAFLD, wherein activated β-catenin was involved in reshaping the tumor-immune microenvironment.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Wong AM, Ding X, Wong AM, et al. Unique molecular characteristics of NAFLD-associated liver cancer accentuate β-catenin/TNFRSF19-mediated immune evasion. J Hepatol. 2022. PMID: 35351523. doi:10.1016/j.jhep.2022.03.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。